The study of pulmonary circulation in the patients with pulmonary sarcoidosis Source: Eur Respir J 2001; 18: Suppl. 33, 415s Year: 2001
Central European idiopathic pulmonary fibrosis (IPF) patients survey Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis Year: 2019
Respiratory infections in patients with idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2009 - Idiopathic pulmonary fibrosis: concepts and mechanisms Year: 2009
Charectristics of pulmonary cavitary lesion in patients with pulmonary TB Source: Eur Respir J 2004; 24: Suppl. 48, 284s Year: 2004
Characteristics of pulmonary cavitary lesions in patients with pulmonary TB Source: Eur Respir J 2004; 24: Suppl. 48, 199s Year: 2004
Characteristics of pulmonary cavitary lesions in patients with pulmonary TB Source: Eur Respir J 2003; 22: Suppl. 45, 247s Year: 2003
Characteristics of pulmonary cavitary lesions in patients with pulmonary TB Source: Eur Respir J 2006; 28: Suppl. 50, 28s Year: 2006
Pulmonary tuberculosis (TB) as a complication of idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2009 - A wide spectrum of idiopathic pulmonary fibrosis Year: 2009
Pulmonary hypertension is common in end-stage sarcoidosis Source: Annual Congress 2005 - Progresses in granolomatous lung disease Year: 2005
Are pulmonary and extra-pulmonary features affected in patients with Beta-thalassemia? Source: Virtual Congress 2021 – Peripheral muscle function, exercise capacity and functional status in respiratory disease Year: 2021
Autoreactivity in patients with respiratory sarcoidosis. Source: International Congress 2018 – Sarcoidosis: from basic research to patient outcomes Year: 2018
Pulmonary hypertension (PH) and features of pulmonary circulation in patient with lung sarcoidosis (LS) Source: Eur Respir J 2006; 28: Suppl. 50, 354s Year: 2006
Clinical experience with Nintedanib for treatment of idiopathic pulmonary fibrosis (IPF) in Spain. Source: International Congress 2017 – Idiopathic pulmonary fibrosis: from the bench to the bedside Year: 2017
Which patients are SaPHe in sarcoidosis-associated pulmonary hypertension? Source: Eur Respir J, 55 (5) 2000700; 10.1183/13993003.00700-2020 Year: 2020
A study of pulmonary parenchymal and vascular disease in patients with familial Mediterranean fever (fmf) Source: Annual Congress 2009 - Pulmonary hypertension Year: 2009
Neutrophil-rich inflammation in induced sputum of patients with idiopathic pulmonary fibrosis (IPF) Source: Eur Respir J 2001; 18: Suppl. 33, 409s Year: 2001
The prevalence of pulmonary parenchymal tuberculosis in patients with tuberculous pleuritis Source: Eur Respir J 2005; 26: Suppl. 49, 690s Year: 2005
Pulmonary hypertension associated with sarcoidosis Source: Eur Respir Mon 2012; 57: 166-181 Year: 2012
Towards a better diagnosis of idiopathic pulmonary fibrosis (IPF) Source: Annual Congress 2010 - Idiopathic pulmonary fibrosis: present understandings and future directions Year: 2010
Allergic/invasive pulmonary aspergillosis in CGD (chronic granulomatous disease) patients Source: Annual Congress 2009 - Host factors in paediatric bacterial respiratory infection Year: 2009